State IA
Clinical Trials in Iowa
Recruiting clinical trials with at least one study location in Iowa. Data updated daily from ClinicalTrials.gov.
Top Conditions in Iowa
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Malignant Neoplasm (2)Myeloproliferative Neoplasm (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Acute Myeloid Leukemia (2)Parkinson Disease (2)Atrial Fibrillation (2)
NCT06499805 N/A
Recruiting
Barriers and Facilitators to OTC Hearing Aids Success
Condition
Hearing Loss, Sensorineural
Enrollment
360 pts
Location
United States
Sponsor
Yu-Hsiang Wu
NCT05653973 EARLY_Phase 1
Recruiting
Prenatal Aspirin and Postpartum Vascular Function
Condition
Preeclampsia
Enrollment
60 pts
Location
United States
Sponsor
Anna Stanhewicz, PhD
NCT07199569 Phase 2
Recruiting
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production C...
Condition
Monkeypox (Mpox)
Enrollment
744 pts
Location
United States
Sponsor
Bavarian Nordic
NCT06168461 EARLY_Phase 1
Recruiting
Daily Aspirin Treatment After Preeclampsia
Condition
Preeclampsia
Enrollment
40 pts
Location
United States
Sponsor
Anna Stanhewicz, PhD
NCT05481879 Phase 1, Phase 2
Recruiting
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DY...
Condition
Myotonic Dystrophy Type 1 (DM1)
Enrollment
116 pts
Location
United States, Australia, France
Sponsor
Dyne Therapeutics
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT06696014 N/A
Recruiting
Mirikizumab Real World Protocol
Condition
Ulcerative Colitis
Enrollment
100 pts
Location
United States, Canada
Sponsor
University of North Carolina,
NCT07166406 Phase 3
Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Pat...
Condition
Advanced Hepatocellular Carcinoma
Enrollment
252 pts
Location
United States
Sponsor
NRG Oncology
NCT05534243 N/A
Recruiting
The ED-AWARENESS-2 Trial
Condition
Awareness
Enrollment
3,090 pts
Location
United States
Sponsor
Washington University School o
NCT05057676 N/A
Recruiting
Autoimmune Intervention Mastery Course Study
Condition
Multiple Sclerosis
Enrollment
400 pts
Location
United States
Sponsor
Terry L. Wahls
NCT06902558 Phase 2
Recruiting
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of A...
Condition
Autosomal Dominant Polycystic Kidney Disease
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT06667076 Phase 2
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combina...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
480 pts
Location
United States, Belgium, Finland
Sponsor
Janssen Research & Development
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
NCT06191640 N/A
Recruiting
Sinus Disease in Young Children With Cystic Fibrosis
Condition
Cystic Fibrosis in Children
Enrollment
80 pts
Location
United States
Sponsor
University of California, Los
NCT02708134 N/A
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Condition
Cardiac Arrest
Enrollment
7,000 pts
Location
United States, Australia, Brazil
Sponsor
Children's Hospital of Philade
NCT05773274 Phase 2
Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patie...
Condition
Metastatic Digestive System Neuroendocrine Tumor G1
Enrollment
100 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05696613 Phase 3
Recruiting
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Condition
Primary Membranous Nephropathy
Enrollment
148 pts
Location
United States, Canada, India
Sponsor
Cerium Pharmaceuticals, Inc.
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
Page 5 of 5 — 119 trials total